Direct effect of dehydroepiandrosterone sulfate (DHEAS) on PC-12 cell differentiation processes

Molecular and Cellular Endocrinology

Volumn 336, Issue 1-2, 2011, Pages 149-155

  Ziegler, Christian G ^a   Langbein, Heike ^a   Krug, Alexander W ^a   Ludwig, Barbara ^a   Eisenhofer, Graeme ^a   Ehrhart Bornstein, Monika ^a   Bornstein, Stefan R ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Dehydroepiandrosterone sulfate; Estrone sulfamate; Steroid sulfatase

Indexed keywords

BOVINE SERUM ALBUMIN; CHROMOGRANIN A; MITOGEN ACTIVATED PROTEIN KINASE 1; NERVE GROWTH FACTOR; PRASTERONE; PRASTERONE SULFATE; STERYL SULFATASE; SYNAPTOSOMAL ASSOCIATED PROTEIN 25;

ANDROGEN METABOLISM; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN; CHROMAFFIN CELL; CONTROLLED STUDY; DOPAMINE RELEASE; ENZYME INHIBITION; HORMONE ACTION; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL MEMBRANE PERMEABILITY; CHROMOGRANIN A; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; DOPAMINE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; NERVE GROWTH FACTOR; NEURITES; NEUROSECRETORY SYSTEMS; PC12 CELLS; PHOSPHORYLATION; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SERUM ALBUMIN, BOVINE; STERYL-SULFATASE; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25; TIME FACTORS;

EID: 79952071509     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.12.031     Document Type: Article

References (29)

1. Arlt W., Stewart P.M. Adrenal corticosteroid biosynthesis, metabolism, and action. Endocrinol. Metab. Clin. North Am. 2005, 34:293-313.
2. Beaujean D., Rosenbaum C., Muller H.W., Willemsen J.J., Lenders J., Bornstein S.R. Combinatorial code of growth factors and neuropeptides define neuroendocrine differentiation in PC12 cells. Exp. Neurol. 2003, 184:348-358.
3. Burger H.G. Androgen production in women. Fertil. Steril. 2002, 77:3-5.
4. Charalampopoulos I., Alexaki V.I., Lazaridis I., Dermitzaki E., Avlonitis N., Tsatsanis C., Calogeropoulou T., Margioris A.N., Castanas E., Gravanis A. G protein-associated, specific membrane binding sites mediate the neuroprotective effect of dehydroepiandrosterone. FASEB J. 2006, 20:577-579.
5. Charalampopoulos I., Dermitzaki E., Vardouli L., Tsatsanis C., Stournaras C., Margioris A.N., Gravanis A. Dehydroepiandrosterone sulfate and allopregnanolone directly stimulate catecholamine production via induction of tyrosine hydroxylase and secretion by affecting actin polymerization. Endocrinology 2005, 146:3309-3318.
6. Chen F., Knecht K., Birzin E., Fisher J., Wilkinson H., Mojena M., Moreno C.T., Schmidt A., Harada S., Freedman L.P., Reszka A.A. Direct agonist/antagonist functions of dehydroepiandrosterone. Endocrinology 2005, 146:4568-4576.
7. Compagnone N.A., Mellon S.H. Dehydroepiandrosterone: a potential signalling molecule for neocortical organization during development. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:4678-4683.
8. Eaton M.J., Duplan H. Useful cell lines derived from the adrenal medulla. Mol. Cell Endocrinol. 2004, 228:39-52.
9. Ehrhart-Bornstein M., Breidert M., Guadanucci P., Wozniak W., Bocian-Sobkowska J., Malendowicz L.K., Bornstein S.R. 17 alpha-hydroxylase and chromogranin A in 6th week human fetal adrenals. Horm. Metab. Res. 1997, 29:30-32.
10. Ehrhart-Bornstein M., Hinson J.P., Bornstein S.R., Scherbaum W.A., Vinson G.P. Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr. Rev. 1998, 19:101-143.
11. Hammer F., Subtil S., Lux P., Maser-Gluth C., Stewart P.M., Allolio B., Arlt W. No evidence for hepatic conversion of dehydroepiandrosterone (DHEA) sulfate to DHEA: in vivo and in vitro studies. J. Clin. Endocrinol. Metab. 2005, 90:3600-3605.
12. Ii M., Hoshiga M., Negoro N., Fukui R., Nakakoji T., Kohbayashi E., Shibata N., Furutama D., Ishihara T., Hanafusa T., Losordo D.W., Ohsawa N. Adrenal androgen dehydroepiandrosterone sulfate inhibits vascular remodeling following arterial injury. Atherosclerosis 2009, 206:77-85.
13. Kim Y., Seger R., Suresh Babu C.V., Hwang S.Y., Yoo Y.S. A positive role of the PI3-K/Akt signaling pathway in PC12 cell differentiation. Mol. Cell 2004, 18:353-359.
14. Krug A.W., Grossmann C., Schuster C., Freudinger R., Mildenberger S., Govindan M.V., Gekle M. Aldosterone stimulates epidermal growth factor receptor expression. J. Biol. Chem. 2003, 278:43060-43066.
15. Krug A.W., Langbein H., Ziegler C.G., Bornstein S.R., Eisenhofer G., Ehrhart-Bornstein M. Dehydroepiandrosterone-sulphate (DHEA-S) promotes neuroendocrine differentiation of chromaffin pheochromocytoma PC12 cells. Mol. Cell Endocrinol. 2009, 300:126-131.
16. Liu D., Dillon J.S. Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Galpha(i2,3). J. Biol. Chem. 2002, 277:21379-21388.
17. Liu D., O'Leary B., Iruthayanathan M., Love-Homan L., Perez-Hernandez N., Olivo H.F., Dillon J.S. Evaluation of a novel photoactive and biotinylated dehydroepiandrosterone analog. Mol. Cell Endocrinol. 2010, [Epub ahead of print].
18. Liu S.L., Schmuck S., Chorazcyzewski J.Z., Gros R., Feldman R.D. Aldosterone regulates vascular reactivity: short-term effects mediated by phosphatidylinositol 3-kinase-dependent nitric oxide synthase activation. Circulation 2003, 108:2400-2406.
19. Maninger N., Wolkowitz O.M., Reus V.I., Epel E.S., Mellon S.H. Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front. Neuroendocrinol. 2009, 30:65-91.
20. Mesiano S., Jaffe R.B. Developmental and functional biology of the primate fetal adrenal cortex. Endocr. Rev. 1997, 18:378-403.
21. Radford D.J., Wang K., McNelis J.C., Taylor A.E., Hechenberger G., Hofmann J., Chahal H., Arlt W., Lord J.M. Dehdyroepiandrosterone sulfate directly activates protein kinase C-beta to increase human neutrophil superoxide generation. Mol. Endocrinol. 2010, 24:813-821.
22. Rosenfeld R.S., Rosenberg B.J., Hellman L. Direct analysis of dehydroisoandrosterone in plasma. Steroids 1975, 25:799-805.
23. Sicard F., Ehrhart-Bornstein M., Corbeil D., Sperber S., Krug A.W., Ziegler C.G., Rettori V., McCann S.M., Bornstein S.R. Age-dependent regulation of chromaffin cell proliferation by growth factors, dehydroepiandrosterone (DHEA), and DHEA sulfate. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:2007-2012.
24. Sicard F., Krug A.W., Ziegler C.G., Sperber S., Ehrhart-Bornstein M., Bornstein S.R. Role of DHEA and growth factors in chromaffin cell proliferation. Ann. N.Y. Acad. Sci. 2006, 1073:312-316.
25. Stanway S.J., Delavault P., Purohit A., Woo L.W., Thurieau C., Potter B.V., Reed M.J. Steroid sulfatase: a new target for the endocrine therapy of breast cancer. Oncologist 2007, 12:370-374.
26. Vaudry D., Stork P.J., Lazarovici P., Eiden L.E. Signaling pathways for PC12 cell differentiation: making the right connections. Science 2002, 296:1648-1649.
27. Xiao J., Zhou Q., Liu Y. Variant PC12 cell line that spontaneously differentiates and extends neuritic processes. J. Neurosci. Res. 2002, 69:104-109.
28. Ziegler C.G., Sicard F., Lattke P., Bornstein S.R., Ehrhart-Bornstein M., Krug A.W. Dehydroepiandrosterone induces a neuroendocrine phenotype in nerve growth factor-stimulated chromaffin pheochromocytoma PC12 cells. Endocrinology 2008, 149:320-328.
29. Ziegler C.G., Sicard F., Sperber S., Ehrhart-Bornstein M., Bornstein S.R., Krug A.W. DHEA reduces NGF-mediated cell survival in serum-deprived PC12 cells. Ann. N.Y. Acad. Sci. 2006, 1073:306-311.